Front. Endocrinol. Frontiers in Endocrinology Front. Endocrinol. 1664-2392 Frontiers Media S.A. 10.3389/fendo.2025.1754016 Correction Correction: Determinants of adverse event occurrence in children with short stature born small for gestational age treated with growth hormone CoutantRegis 1 * † Formal analysis Validation Methodology Supervision Writing – review & editing Conceptualization Investigation Writing – original draft BenchikhNazim 2 Methodology Writing – review & editing Conceptualization Supervision Investigation Formal analysis Validation LinglartAgnès 3 † Validation Methodology Formal analysis Investigation Writing – review & editing Conceptualization Supervision NicolinoMarc 4 † Validation Formal analysis Writing – original draft Supervision Investigation Conceptualization Methodology SallesJean-Pierre 5 † Methodology Formal analysis Supervision Investigation Writing – review & editing Conceptualization Validation Department of Paediatric Endocrinology, University Hospital, Angers, France Rare Endocrine Disorders, Clinical Medical and Regulatory, Novo Nordisk, Paris, France AP-HP, Paris Saclay University, INSERM, Physiologie et Physiopathologie Endocriniennes, Endocrinology and Diabetology for Children, Bicêtre Paris Saclay Hospital, Le Kremlin-Bicetre, France Division of Pediatric Endocrinology and Metabolism, Lyon University Pediatric Hospital, Lyon, France Endocrinology and Bone Diseases Unit, Children’s Hospital, Toulouse University Hospital, University of Toulouse Paul Sabatier, INSERM-CNRS Unit 1291, Infinity Center, Toulouse, France Correspondence: Regis Coutant, recoutant@chu-angers.fr

ORCID: Regis Coutant, orcid.org/0000-0002-6332-4243; Agnès Linglart, orcid.org/0000-0003-3455-002X; Marc Nicolino, orcid.org/0000-0001-5395-2249; Jean-Pierre Salles, orcid.org/0000-0002-0941-8951

 08 12 2025 2025 16 1754016 25 11 2025 28 11 2025 Copyright © 2025 Coutant, Benchikh, Linglart, Nicolino and Salles. 2025 Coutant, Benchikh, Linglart, Nicolino and Salles https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. A Correction on Determinants of adverse event occurrence in children with short stature born small for gestational age treated with growth hormone By Coutant R, Benchikh N, Linglart A, Nicolino M and Salles J-P (2025) Front. Endocrinol. 16:1656966. doi: 10.3389/fendo.2025.1656966 growth hormone small for gestational age adverse events serious adverse events real-world data Novo Nordisk 10.13039/501100004191 section-at-acceptance Pediatric Endocrinology

The reference for “23. World Medical Association (2004)” was erroneously written as “23. World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. J Int Bioethique. (2004) 15:124–9. doi: 10.1001/jama.2013.281053”. It should be “23. World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. J Int Bioethique. (2004) 15(1):124–9”.

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Edited and reviewed by: Michael Freemark, Duke University, United States